FAM46C was suggested to function as an oncosuppressor not only in MM but also in colorectal (9), prostate (10), and gastric (11) cancer and in hepatocellular (12) and oral squamous cell (13) carcinoma. The gene discussed is TENT5C; the disease is Miyoshi myopathy.